Greenland Mines (NASDAQ: GRML) announced the completion of a three-day, multidisciplinary planning workshop for its Skaergaard Precious and Critical Metals Project in southeast Greenland. The event, held June 22-24, brought together more than 15 international experts from GTK Mintec, the Geological Survey of Finland, SLR Consulting, WSP Denmark, and other technical specialists. The workshop focused on advancing understanding of the orebody and processing pathways, planning 2026 drilling, sampling, and environmental programs, and establishing a roadmap toward an Initial Assessment (IA) or Preliminary Economic Assessment (PEA) and future development.
The company stated that the workshop produced an integrated plan for the 2026 field campaign, a refined metallurgical testing strategy, a framework for incorporating geotechnical and environmental data into mine design and permitting, and a long-term development roadmap extending toward a potential exploitation license. This initiative builds on existing collaborations with GTK Mintec, WSP Denmark, and SLR Consulting, reflecting Greenland Mines' strategy of engaging leading international technical experts to advance the Skaergaard project.
The Skaergaard Project is a significant asset in Greenland's mineral-rich region, and the workshop's outcomes are expected to accelerate its development. The integration of expert input from multiple disciplines underscores the company's commitment to thorough, data-driven planning. As Greenland Mines moves toward an IA or PEA, the project's progress could have implications for the supply of precious and critical metals, which are vital for various technological and industrial applications.
For more details, the full press release is available at https://ibn.fm/LP1cL. Greenland Mines is a Nasdaq-listed company with two operating divisions: mining, focused on exploration and development of the Skaergaard Project and, subject to closing of a previously announced transaction, the Sarfartoq neodymium-praseodymium rare earths project; and biotech, including Klotho’s KLTO-202 primary indication for ALS. The company’s strategy centers on building a multi-asset platform with exposure to rare earth magnet materials, precious metals, and selected midstream processing opportunities, while advancing its North Atlantic Critical Metals Corridor vision.
Forward-looking statements in this article involve risks and uncertainties, as detailed in the company's filings with the SEC. Readers are cautioned not to place undue reliance on these statements. The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML.
